A Phase 3 study of S-474474 in patients with essential hypertensio
Phase 3
- Conditions
- Hypertension
- Registration Number
- JPRN-jRCT2080221505
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with essential hypertension who meet the following criteria:
Seated systolic blood pressure is >=150 mmHg and <200 mmHg, and diastolic blood pressure >=95 mmHg and <115 mmHg, etc.
Exclusion Criteria
Patients with renal, hepatic or heart disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in trough seated diastolic blood pressure
- Secondary Outcome Measures
Name Time Method Change in trough seated systolic pressure, normalization rate, the incidents of adverse events and adverse drug reactions, etc